Clinical trials

  • DS-1062a for Non-small cell lung cancer
  • Nusinersen for Spinal Muscular Atrophy
  • Semaglutide for Chronic kidney disease
  • Patritumab deruxtecan (U3-1402) for Advanced breast cancer | Hormone receptor-positive (HR+) HER2-negative advanced breast cancer
  • brentuximab vedotin for Hodgkin lymphoma
  • EPCORITAMAB for Follicular lymphoma (relapsed or refractory)
  • SEBETRALSTAT for Hereditary angioedema (Type I or II)
  • DURVALUMAB for Esophageal squamous cell carcinoma|Locally advanced unresectable esophageal squamous cell carcinoma
  • non-absorbed, cation exchange polymer for Chronic kidney disease (stage 3b-4)
  • TIN816 for Sepsis-associated acute kidney injury|Acute kidney injury|Sepsis
  • Sacituzumab tirumotecan for Advanced urothelial carcinoma | Urothelial carcinoma
  • GLOFITAMAB for Relapsed/refractory B-cell non-Hodgkin lymphoma | Diffuse large B-cell lymphoma | Follicular lymphoma | Mantle cell lymphoma